Biotech Group Acquisition Corp

Biotech Group Acquisition Corp (Nasdaq: BGAC) is a blank check company that filed its S-1 registration statement with the SEC on April 15, 2022, targeting an acquisition in the biotechnology and life sciences sector. The SPAC was sponsored by Biotech Group Acquisition Sponsor LLC and completed its initial public offering in 2022. As a life-sciences-focused vehicle, BGAC was formed with the stated intention of identifying and combining with a company operating in the biotech, pharmaceutical, or related healthcare innovation space. For current deal status, extension history, and full filing detail on BGAC and hundreds of other active and historical SPACs, create a free account at SpacDesk.